Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 71

Related Articles by Review for PubMed (Select 15837750)

1.

Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.

Stams WA, den Boer ML, Beverloo HB, Meijerink JP, van Wering ER, Janka-Schaub GE, Pieters R.

Clin Cancer Res. 2005 Apr 15;11(8):2974-80.

2.

The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.

Lo Coco F, Pisegna S, Diverio D.

Haematologica. 1997 May-Jun;82(3):364-70. Review.

3.

[The role of TEL and AML1 genes in the pathogenesis of hematologic malignancies].

Zuna J.

Cas Lek Cesk. 2001 Mar 15;140(5):131-7. Review. Czech.

PMID:
11347199
4.

Detection of the Der (21)t(12;21) chromosome forming the TEL-AML1 fusion gene in childhood acute lymphoblastic leukemia.

Kobayashi H, Satake N, Kaneko Y.

Leuk Lymphoma. 1997 Dec;28(1-2):43-50. Review.

PMID:
9498702
6.
7.

Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia.

Zelent A, Greaves M, Enver T.

Oncogene. 2004 May 24;23(24):4275-83. Review.

PMID:
15156184
8.

AML1 amplification in a child with acute lymphoblastic leukemia.

Alvarez Y, Coll MD, Bastida P, Ortega JJ, Caballín MR.

Cancer Genet Cytogenet. 2003 Jan 1;140(1):58-61. Review.

PMID:
12550760
9.

The role of TEL fusion genes in pediatric leukemias.

Rubnitz JE, Pui CH, Downing JR.

Leukemia. 1999 Jan;13(1):6-13. Review.

PMID:
10049061
10.

Mechanisms of transcriptional repression by the t(8;21)-, t(12;21)-, and inv(16)-encoded fusion proteins.

Heibert SW, Lutterbach B, Durst K, Wang L, Linggi B, Wu S, Wood L, Amann J, King D, Hou Y.

Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S31-4. Review.

PMID:
11587363
11.

The TEL gene contributes to the pathogenesis of myeloid and lymphoid leukemias by diverse molecular genetic mechanisms.

Golub TR, Barker GF, Stegmaier K, Gilliland DG.

Curr Top Microbiol Immunol. 1997;220:67-79. Review. No abstract available.

PMID:
9103676
12.

Involvement of the TEL gene in hematologic malignancy by diverse molecular genetic mechanisms.

Golub TR, Barker GF, Stegmaier K, Gilliland DG.

Curr Top Microbiol Immunol. 1996;211:279-88. Review. No abstract available.

PMID:
8585959
13.

AML1 interconnected pathways of leukemogenesis.

Michaud J, Scott HS, Escher R.

Cancer Invest. 2003;21(1):105-36. Review. Erratum in: Cancer Invest. 2003;21(4):659.

PMID:
12643014
14.

Core binding factor (CBF) acute myeloid leukemia: is molecular monitoring by RT-PCR useful clinically?

Marcucci G, Caligiuri MA, Bloomfield CD.

Eur J Haematol. 2003 Sep;71(3):143-54. Review.

PMID:
12930314
15.

AML1/RUNX1 fusion gene and t(5;21)(q13;q22) in a case of chronic myelomonocytic leukemia with progressive thrombocytopenia and monocytosis.

Liu S, Li C, Bo L, Dai Y, Xiao Z, Wang J.

Cancer Genet Cytogenet. 2004 Jul 15;152(2):172-4. Review. No abstract available.

PMID:
15262442
16.

TEL/AML1-positive pediatric leukemia: prognostic significance and therapeutic approaches.

Loh ML, Rubnitz JE.

Curr Opin Hematol. 2002 Jul;9(4):345-52. Review.

PMID:
12042710
17.

Molecular cytogenetics of t(12;21) (p13;q22).

Bernard OA, Romana SP, Poirel H, Berger R.

Leuk Lymphoma. 1996 Nov;23(5-6):459-65. Review.

PMID:
9031076
18.

Identification of two new translocations that disrupt the AML1 gene.

Richkind K, Hromas R, Lytle C, Crenshaw D, Velasco J, Roherty S, Srinivasiah J, Varella-Garcia M.

Cancer Genet Cytogenet. 2000 Oct 15;122(2):141-3. Review.

PMID:
11106827
19.

AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML.

Licht JD.

Oncogene. 2001 Sep 10;20(40):5660-79. Review. No abstract available.

20.

Acute lymphoblastic leukemia and chromosome 21.

Berger R.

Cancer Genet Cytogenet. 1997 Mar;94(1):8-12. Review.

PMID:
9078285
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk